166 related articles for article (PubMed ID: 18049159)
1. Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea.
Kim DY; Ahn SH; Lee HW; Kim SU; Kim JK; Paik YH; Lee KS; Han KH; Chon CY
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):923-6. PubMed ID: 18049159
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of anti-HAV among patients with chronic viral liver disease.
Cho HC; Paik SW; Kim YJ; Choi MS; Lee JH; Koh KC; Yoo BC; Son HJ; Kim SW
World J Gastroenterol; 2011 Jan; 17(2):236-41. PubMed ID: 21245998
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis A seroprevalence in patients with chronic viral hepatitis in Konya, Turkey.
Özden HT
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):333-7. PubMed ID: 26703930
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
[TBL] [Abstract][Full Text] [Related]
6. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
[TBL] [Abstract][Full Text] [Related]
7. Is vaccination against hepatitis A virus required in patients with cirrhosis of the liver?
Duseja A; Sharma S; Das K; Dhiman RK; Chawla YK
Trop Gastroenterol; 2004; 25(4):162-3. PubMed ID: 15912973
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea.
Lee SH; Kim HS; Park KO; Park JW; Chun SY; Lim SJ; Cho HJ; Kim SJ; Park HW; Moon HK; Shin WG; Kim KH; Jang MK; Lee JH; Kim HY
Korean J Hepatol; 2010 Dec; 16(4):362-8. PubMed ID: 21415579
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to hepatitis A virus infection among chronic liver disease patients and healthy blood donors in Thailand.
Pramoolsinsap C; Attamasirul K; Busagorn N; Maneerat Y; Nuchprayoon C; Tanprasert S; Srivatanakul P; Theamboonlers A; Hirsch P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):91-5. PubMed ID: 10695795
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of hepatitis A virus in patients with chronic liver disease from Kerala: impact on vaccination policy.
John A; Chatni S; Narayanan VA; Balakrishnan V; Nair P
J Indian Med Assoc; 2009 Dec; 107(12):859-61. PubMed ID: 20509469
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis A vaccination in chronic liver disease: is it really required in a tropical country like India?
Joshi N; Rao S; Kumar A; Patil S; Rani S
Indian J Med Microbiol; 2007 Apr; 25(2):137-9. PubMed ID: 17582184
[TBL] [Abstract][Full Text] [Related]
12. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?
Anand AC; Nagpal AK; Seth AK; Dhot PS
J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855
[TBL] [Abstract][Full Text] [Related]
13. Laboratory characteristics of recent hepatitis A in Korea: ongoing epidemiological shift.
Moon HW; Cho JH; Hur M; Yun YM; Choe WH; Kwon SY; Lee CH
World J Gastroenterol; 2010 Mar; 16(9):1115-8. PubMed ID: 20205283
[TBL] [Abstract][Full Text] [Related]
14. Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study.
Sagnelli E; Stroffolini T; Almasio P; Mele A; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P
J Viral Hepat; 2006 Jan; 13(1):67-71. PubMed ID: 16364085
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of hepatitis A virus antibody in patients with chronic liver disease--experience from a tertiary care hospital in north India.
Dhotial A; Kapoor D; Kumar N
Trop Gastroenterol; 2002; 23(4):170-1. PubMed ID: 12833702
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
[TBL] [Abstract][Full Text] [Related]
18. Retrospectively seroprevalence study on anti-HEV-IgG antibody in patients with chronic hepatitis or liver cirrhosis in a Chinese teaching hospital.
Yang H; Wu J; Yuan Y; Huang W; Jia B
J Med Virol; 2019 Mar; 91(3):437-443. PubMed ID: 30307619
[TBL] [Abstract][Full Text] [Related]
19. [The seroprevalence rate, vaccination rate and seroconversion rate of hepatitis A in central region of Korea].
Yun SW; Lee WK; Cho SY; Moon SH; Shin HD; Yun SY; Kim SB; Shin JE; Kim HJ; Song IH; Lee KS; Lee JH
Korean J Gastroenterol; 2011 Mar; 57(3):166-72. PubMed ID: 21519164
[TBL] [Abstract][Full Text] [Related]
20. [The age-specific seroprevalence of hepatitis A virus antibody in Korea].
Song YB; Lee JH; Choi MS; Koh KC; Paik SW; Yoo BC; Choi YH; Sohn HJ; Lee KH; Rhee JC
Korean J Hepatol; 2007 Mar; 13(1):27-33. PubMed ID: 17380072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
